Policy and advocacy: campaigning for change
We’re championing the needs of people living with blood cancer
This year 19,403 Australians will be newly diagnosed with blood cancer such as leukaemia, lymphoma and myeloma. This is equivalent to 53 people every day or one person every 27 minutes.
We advocate for better policies, better access to new and innovative treatments, better diagnostics and, ultimately, better outcomes so that more people live through blood cancer and live well.
In 2019, the Leukaemia Foundation was commissioned by the Australian Government to develop and deliver our first ever National Strategic Action Plan for Blood Cancer on behalf of the blood cancer community. We also help to fast-track affordable access to innovative treatments by engaging with governments at all levels.
In 2022 we made 14 submissions supporting the listing of new drugs. Seven of these submissions received a positive recommendation for a PBS listing for blood cancer treatment from the Pharmaceutical Benefits Advisory Committee (PBAC).
